From: High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)
Factor
β
95% CI
p Value
HbA1c
2.683
0.292, 5.074
0.0282
Plaque volume
−0.107
−0.169, –0.046
0.0008